Published in J Cancer on June 18, 2016
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood (2009) 3.56
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood (2013) 3.03
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood (2013) 2.65
Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol (2005) 2.36
Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem (1995) 1.55
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment. Blood (2011) 1.41
Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastroenterol Hepatol (2010) 1.21
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. Lancet Oncol (2015) 1.02
The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab. Am J Clin Pathol (2011) 1.00
MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches. Cancer (2014) 1.00
Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC. Hematology Am Soc Hematol Educ Program (2014) 0.98
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy. Haematologica (2011) 0.98
Outcome and quality of life favour a conservative treatment of patients with primary gastric lymphoma. Z Gastroenterol (2011) 0.89
MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma. Am J Surg Pathol (2015) 0.87
Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). CA Cancer J Clin (2015) 0.85
Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma. Blood (2015) 0.82
The role of infectious agents, antibiotics, and antiviral therapy in the treatment of extranodal marginal zone lymphoma and other low-grade lymphomas. Curr Treat Options Oncol (2015) 0.82
The evolving role of surgery for gastric lymphoma: from curative resection to surgical management of complications. Am Surg (2014) 0.80
Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies. Oncoimmunology (2014) 0.79
Primary Gastrointestinal Lymphoma: A Retrospective Multicenter Clinical Study of 415 Cases in Chinese Province of Guangdong and a Systematic Review Containing 5075 Chinese Patients. Medicine (Baltimore) (2015) 0.78
The t(14;18)(q32;q21)/IGH-MALT1 translocation in gastrointestinal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). Histopathology (2014) 0.78
Correlational study of vascular endothelial growth factor expression and microvessel density in primary malignant gastric lymphoma. Med Oncol (2011) 0.78
Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology. Contemp Oncol (Pozn) (2014) 0.77
Aggressive B-cell lymphomas: a review and practical approach for the practicing pathologist. Adv Anat Pathol (2015) 0.77
Histopathological study using computer database of 10 000 consecutive gastric specimens: (2) malignant lesions. Gastroenterol Rep (Oxf) (2015) 0.77
The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma. Exp Hematol Oncol (2013) 0.77
Using the pathology report in initial treatment decisions for diffuse large B-cell lymphoma: time for a precision medicine approach. Hematology Am Soc Hematol Educ Program (2015) 0.77
Practical Applications in Immunohistochemistry: Evaluation of Diffuse Large B-Cell Lymphoma and Related Large B-Cell Lymphomas. Arch Pathol Lab Med (2015) 0.77
The Role of Surgery in the Clinical Management of Primary Gastrointestinal Non-Hodgkin's Lymphoma. Am Surg (2015) 0.77